Related Experiment Video
Updated: Jun 23, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
Clemens A Schmitt1, Jordan S Fridman, Meng Yang
1Cold Spring Harbor Laboratory, 1 Bungtown Road, New York 11724, USA.
Cellular senescence, controlled by p53 and p16(INK4a), impacts chemotherapy response in lymphomas. Tumors with senescence defects show poor outcomes, highlighting senescence
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Mutations in p53 and INK4a/ARF are linked to tumorigenesis and drug resistance by inhibiting apoptosis.
- Cellular senescence is a key tumor suppressor mechanism.
Purpose of the Study:
- To investigate the role of cellular senescence in lymphoma response to chemotherapy.
- To determine the impact of p53 and INK4a/ARF mutations on chemotherapy efficacy in vivo.
Main Methods:
- Treatment of primary murine lymphomas with cyclophosphamide.
- Analysis of p53, p16(INK4a), and senescence markers.
- Assessment of tumor response and mouse prognosis.
Main Results:
- Tumors with p53 or INK4a/ARF mutations responded poorly to cyclophosphamide.
- Drug-induced cytostasis involving senescence markers was observed in tumors with an apoptotic block.
- Acquisition of p53 or INK4a mutations occurred upon progression in drug-treated tumors.
- Tumors capable of drug-induced senescence correlated with better prognosis.
Conclusions:
- Cellular senescence, regulated by p53 and p16(INK4a), is a critical determinant of chemotherapy outcome in lymphomas.
- Senescence defects in tumors lead to poor response to chemotherapy.
- Targeting or preserving senescence pathways may improve cancer treatment strategies.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Replicative Cell Senescence
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
Replicative Cell Senescence